The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 328:1780-1781 June 17, 1993 Number 24
NextNext

What We Learn from Infants with Brain Tumors

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Infants and young children with primary brain tumors pose a unique moral and medical dilemma. For parents and physicians alike, the late neurotoxic effects of radiation therapy in children whose nervous systems are in a critical stage of development are sufficiently formidable to encourage such divergent views as therapeutic nihilism or an enthusiasm for novel treatment alternatives. A major goal for these patients is to develop treatment strategies that minimize the dose of radiation to the central nervous system.

The first step toward reaching this goal would be to demonstrate that an alternative therapy such as parenteral chemotherapy, which is . . . [Full Text of this Article]

References


Related Letters:

Brain Tumors in Infants
Jenkin D., Longcope J. C., Watson S. S., Duffner P. K., Allen J. C., Kun L. E.
Extract | Full Text  
N Engl J Med 1993; 329:1963-1964, Dec 23, 1993. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.